EFFICIENCY OF THE NITRIC OXIDE DONOR MOLSIDOMINE IN THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
According to the results of the latest trials of molsidomine, the latter promotes<i> </i>the decelerated development and stabilization of atherosclerotic plaques.<i> </i>This allows the use of molsidomine to prevent restenoses and opens up fresh<i> </i>opportunities for the treatment of coronary heart disease.